| Trial ID: | L2667 |
| Source ID: | NCT00380380
|
| Associated Drug: |
Vildagliptin
|
| Title: |
A Study to Assess the Acute Effects of Vildagliptin on Gastric Emptying in Patients With Type 2 Diabetes.
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: Vildagliptin
|
| Outcome Measures: |
Primary: Evaluate the effects of acute effects of vildagliptin on gastric emptying | Secondary: Effect on steady state levels of active GLP-1 and GIP|Change in fasting and postprandial glucose levels.|Change in glucagon secretion|Change in postprandial glucose kinetics|Effect on gastric peristalsis|Effect on satiety
|
| Sponsor/Collaborators: |
Sponsor: Novartis
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
18
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE|Primary Purpose: TREATMENT
|
| Start Date: |
2006-01
|
| Completion Date: |
2006-11
|
| Results First Posted: |
|
| Last Update Posted: |
2017-02-23
|
| Locations: |
Munich, 81377, Germany, Munich, Germany
|
| URL: |
https://clinicaltrials.gov/show/NCT00380380
|
